Charles River Laboratories CRL Deferred Foreign Income Tax Expense Benefit
Deferred Foreign Income Tax Expense Benefit at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:DeferredForeignIncomeTaxExpenseBenefit.
The official record: Charles River Laboratories’s 10-K, filed February 18, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's deferred foreign income tax expense benefit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's deferred foreign income tax expense benefit?
- Charles River Laboratories (CRL) reported deferred foreign income tax expense benefit of -$5.6M in Q4 2025.
- How has Charles River Laboratories's deferred foreign income tax expense benefit changed year-over-year?
- Charles River Laboratories's deferred foreign income tax expense benefit decreased by 223.8% year-over-year, from -$1.73M to -$5.6M.
- What is the long-term trend for Charles River Laboratories's deferred foreign income tax expense benefit?
- Over 2 years (2023 to 2025), Charles River Laboratories's deferred foreign income tax expense benefit has grown at a 436.4% compound annual growth rate (CAGR), from $779K to -$22.42M.
- What does deferred foreign income tax expense benefit mean?
- Foreign tax amounts that will be paid or realized in future periods.
- How do you interpret deferred foreign income tax expense benefit?
- Reflects the impact of international accounting and tax timing differences on future cash flows.
- How does deferred foreign income tax expense benefit compare across companies?
- Standard accounting disclosure for multinational firms managing international tax assets and liabilities.